Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 1, 1983Antimicrobial Agents and Chemotherapy

In vitro and in vivo antibacterial activity of AT-2266

View Full Paper
Ask AI
Bookmark
Share

Authors

KKKaoru KOUNOUniversity of TsukubaMIManabu InouePanasonic (Japan)SMS MitsuhashiEuropean Powder Metallugy Association

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

KOUNO et al. (1983) studied this question.

synapsesocial.com/papers/6a72df2a93a4d5cf641ae854https://doi.org/10.1128/aac.24.1.78
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1In vitro activity of norfloxacin, a quinolinecarboxylic acid, compared with that of beta-lactams, aminoglycosides, and trimethoprim1982 · 96 citations
  2. 2Comparative in vitro activity of norfloxacin (MK-0366) and ten other oral antimicrobial agents against urinary bacterial isolates1982 · 71 citations
  3. 3In Vitro Antibacterial Activity of AM-715, a New Nalidixic Acid Analog1980 · 221 citations
  4. 4In vitro antibacterial activity of norfloxacin (MK-0366)1982 · 80 citations
  5. 5In vitro activity of MK-0366 against clinical urinary pathogens including gentamicin-resistant Pseudomonas aeruginosa1982 · 45 citations